Polymyalgia Rheumatica

Conclusions:
Active PMR is characterised by increased serum levels of IL6, but not of other proinflammatory cytokines, that are rapidly suppressed by CS treatment. As circulating monocytes do not show increased production of proinflammatory cytokines, IL6 may be mainly produced in the inflamed tissue. A study of the circulating cytokine profile and its cellular source may provide a clue to new therapeutic options. (Source: Annals of the Rheumatic Diseases)MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed – updated hourly from thousands of authoritative health and news sources.

Read full story

Related posts:

1. Epidemiology of giant cell arteritis and polymyalgia rheumatica ch_client = "wildplus"; ch_width = 200; ch_height = 200; ch_type = "mpu"; ch_sid = "Polymyalgia 200x200"; ch_color_site_link = "#36727D"; ch_color_title...
2. BSR and BHPR guidelines for the management of polymyalgia rheumatica (Source: Rheumatology)MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed – updated...